AN2 Therapeutics, Inc. reports

Company location: Menlo Park, CA
Fiscal year end: 31 December

AN2 Therapeutics, Inc. has filed 381 SEC EDGAR filings since 24 Sep 2021

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 76-100 of 381 matching filings.

Per page

25

Current page

4

4

4

Filing date: 14 Jan 2026
Reporting date: 12 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 14 Jan 2026
Reporting date: 12 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2026
Reporting date: 05 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2026
Reporting date: 05 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2026
Reporting date: 05 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 07 Jan 2026
Reporting date: 05 Jan 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G File 005-93617

SCHEDULE 13G filing

Filing date: 14 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-41331

10-Q

Filing date: 12 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41331

8-K

Filing date: 12 Nov 2025
Reporting date: 12 Nov 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 06 Nov 2025
Reporting date: 04 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Nov 2025
Reporting date: 04 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 14 Oct 2025
Reporting date: 10 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 14 Oct 2025
Reporting date: 10 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 14 Oct 2025
Reporting date: 10 Oct 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-41331

10-Q

Filing date: 12 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-41331

8-K

Filing date: 12 Aug 2025
Reporting date: 12 Aug 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 11 Jul 2025
Reporting date: 10 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Jul 2025
Reporting date: 10 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 11 Jul 2025
Reporting date: 10 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41331

8-K

Filing date: 20 Jun 2025
Reporting date: 17 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13D/A File 005-93617

SCHEDULE 13D/A filing

Filing date: 18 Jun 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Jun 2025
Reporting date: 12 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-41331

8-K

Filing date: 11 Jun 2025
Reporting date: 11 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SCHEDULE 13G File 005-93617

SCHEDULE 13G filing

Filing date: 04 Jun 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Jun 2025
Reporting date: 02 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .